IRIS
ZITO MARINO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.618
AS - Asia 2.295
NA - Nord America 2.283
SA - Sud America 371
AF - Africa 51
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.622
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.835
US - Stati Uniti d'America 2.206
SG - Singapore 727
IT - Italia 558
IE - Irlanda 555
HK - Hong Kong 442
CN - Cina 417
BR - Brasile 321
VN - Vietnam 304
DE - Germania 175
GB - Regno Unito 139
KR - Corea 135
JP - Giappone 99
UA - Ucraina 82
IN - India 63
CA - Canada 58
FR - Francia 52
GR - Grecia 44
FI - Finlandia 39
AT - Austria 22
SE - Svezia 21
TR - Turchia 21
NL - Olanda 20
AR - Argentina 16
ZA - Sudafrica 15
BE - Belgio 14
MX - Messico 13
PK - Pakistan 12
PL - Polonia 12
BD - Bangladesh 10
CH - Svizzera 10
IQ - Iraq 10
MA - Marocco 10
PH - Filippine 9
ES - Italia 8
EC - Ecuador 7
PY - Paraguay 7
MK - Macedonia 6
VE - Venezuela 6
BJ - Benin 5
CL - Cile 5
CZ - Repubblica Ceca 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BG - Bulgaria 4
CO - Colombia 4
ID - Indonesia 4
SA - Arabia Saudita 4
TN - Tunisia 4
AU - Australia 3
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
BA - Bosnia-Erzegovina 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
PA - Panama 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 10.622
Salva come PNG Salva come JPEG
Città #
Moscow 1.456
Dublin 551
Hong Kong 438
Singapore 369
Santa Clara 323
San Jose 302
Chandler 263
Naples 148
Ashburn 134
Seoul 134
Jacksonville 130
Ho Chi Minh City 99
Hanoi 73
Beijing 68
Princeton 67
Roxbury 67
Munich 57
Hefei 54
Dallas 50
Bremen 46
New York 42
Bengaluru 41
Medford 38
Elora 37
Los Angeles 35
São Paulo 34
Aversa 31
Cambridge 29
The Dalles 29
Caserta 26
Des Moines 23
Da Nang 21
Ercolano 21
Nuremberg 21
Wilmington 19
Napoli 18
Boardman 17
Brussels 14
Haiphong 14
Orem 14
Warsaw 12
Biên Hòa 11
Brooklyn 11
Council Bluffs 11
Grumo Nevano 11
San Francisco 11
Ninh Bình 10
Rome 10
Tokyo 10
Vienna 10
Woodbridge 10
Amsterdam 9
Falkenstein 9
Rio de Janeiro 9
Brasília 8
Frankfurt am Main 8
Helsinki 8
Johannesburg 8
Lappeenranta 8
Milan 8
Seattle 8
Stockholm 8
Columbus 7
Düsseldorf 7
Portici 7
Tianjin 7
Afragola 6
Ann Arbor 6
Asunción 6
Atlanta 6
Belo Horizonte 6
Chennai 6
Nanchang 6
Shanghai 6
Thái Nguyên 6
Volla 6
Ariano Irpino 5
Castellammare di Stabia 5
Changsha 5
Curitiba 5
Falls Church 5
Goiânia 5
Guangzhou 5
Hải Dương 5
Jinan 5
Mexico City 5
Montreal 5
San Giuliano 5
Tashkent 5
Turku 5
Baku 4
Boydton 4
Bắc Ninh 4
Bến Tre 4
Chicago 4
Hangzhou 4
Istanbul 4
Jacareí 4
Lausanne 4
London 4
Totale 5.759
Salva come PNG Salva come JPEG
Nome #
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 194
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 181
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 177
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 176
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 169
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 159
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 159
Cytologic diagnosis of metastatic melanoma by FNA: A practical review 159
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 158
A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS-The Experience in Pathological Anatomy Unit 158
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 157
Predictive biomarkers along gastric cancer pathogenetic pathways 149
AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma 148
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 148
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy 146
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 145
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 145
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 144
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 143
Interventional cytopathology in COVID-19 ERA 143
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 139
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 135
A new look at the ALK gene in cancer: copy number gain and amplification 135
Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies 135
To Get the Most out of the Least: BRAF Molecular Evaluation in Melanoma Metastases on Cell Suspension from Fine Needle Aspiration Cytology Needle Rinses 134
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond 134
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors 134
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 133
GOLPH3 promotes oncogenesis by controlling the intra-Golgi trafficking of glycosphingolipid synthases 132
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 131
HER2 EXPRESSION IN GASTROINTESTINAL TUMOR. A FOCUS ON DIAGNOSTIC ALGORITHM OF HER2. STATUS FROM GASTRIC TO INTESTINAL CANCER 131
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 131
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 129
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 129
Correction: Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 128
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers 127
Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method 125
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 125
AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma 124
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC 121
Concomitant ALK/KRAS and ALK/EGFR mutations in non small cell lung cancer: Different profile of response to target therapies 121
Second Diagnostic Opinion by Experienced Dermatopathologists in the Setting of a Referral Regional Melanoma Unit Significantly Improves the Clinical Management of Patients With Cutaneous Melanoma 121
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples 120
Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods 119
MALT GASTRIC LYMPHOMA: AN UPDATE OF PATHOGENETIC FEATURES 118
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 116
Mesenchymal neoplasms: Is it time for cytology? New perspectives for the pre-operative diagnosis of soft tissue tumors in the molecular era 115
Diagnostic accuracy of FNA cytology for diagnosis of salivary gland tumors in pediatric patients 114
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 114
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems 113
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 113
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 111
Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients 111
Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features 111
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 109
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 107
Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features 107
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV 107
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 106
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 105
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas 104
The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules 103
COVID-19: detection methods in post-mortem samples 102
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 102
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 101
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 100
CRISPR-barcoding in non small cell lung cancer: From intratumor genetic heterogeneity modeling to cancer therapy application 100
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 100
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis 100
New therapeutic perspectives in CCDC6 deficient lung cancer cells 99
How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls 97
Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features 97
Mitochondrial AKAP1 supports mTOR pathway and tumor growth 96
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS 95
Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma 95
The GOLPH3 oncogene controls the intra-Golgi recycling of sphingolipid glycosylating enzymes to promote proliferation 93
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era 92
Nivolumab in heavily pretreated metastatic gastric cancer patients: Real-life data from a western population 89
Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks 88
Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy 88
Immunohistochemistry for cancer stem cells detection: Principles and methods 84
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer 83
The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 82
RNAScope in situ Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor 79
NTRK Gene Fusion Detection in Atypical Spitz Tumors 76
Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors 75
Detection of ROSI rearrangement in non-small cell lung cancer: Current and future perspectives 70
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multi-institutional research study 68
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 67
Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples 51
The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism 48
Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma 46
Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology 17
MTAP in small biopsy samples of pancreatic lesions: a potential diagnostic biomarker. Immunohistochemical, fluorescence in situ hybridization and molecular analysis 15
BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samples 11
Totale 10.841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 0 0 0 0 54 49 7
2021/2022486 5 12 3 4 126 7 30 10 22 48 75 144
2022/20231.093 128 36 20 87 99 80 11 52 524 14 18 24
2023/2024502 44 27 25 33 145 41 20 17 12 11 45 82
2024/20251.686 24 19 12 34 301 235 268 174 232 193 124 70
2025/20266.427 285 396 296 288 555 3.568 365 317 206 151 0 0
Totale 10.841